U.S., April 7 -- ClinicalTrials.gov registry received information related to the study (NCT07513038) titled 'Use of Indocyanine Green (ICG) for the Diagnosis of Biliary Atresia' on Feb. 25, 2025.
Brief Summary: Biliary atresia is a rare, progressive liver disease that only affects infants. It leads to complete obstruction and scarring of the bile duct. Current non-invasive diagnostic tests have limited sensitivity.
Indocyanine Green (ICG) is a non-radioactive, fluorescent compound with several clinical applications including angiography for ophthalmologic testing, visualization during surgery, and measurement of liver function. After excitation with near infrared light (750-810 nm), ICG emits near infrared light at 850 nm, which can be de...